loading

왜 Myriad Genetics Inc (MYGN) 주가가 하락하고 있습니까?

2025-04-10 거래 세션 동안 Myriad Genetics Inc(MYGN) 주식이 5.92% 하락한 것을 확인했습니다. 이는 정상적인 변동성이나 다양한 내부 및 외부 요인에 의한 것일 수 있지만, 상황을 적극적으로 모니터링하고 있으며 최대한 빨리 적시에 업데이트를 제공하도록 하겠습니다!
2023-11-09:

Shares of Myriad Genetics (MYGN) dropped by 8.94% from $17.89 to $16.29 in the trading on Thursday, Novemeber 9, 2023. The reason why MYGN down is due to the announcement of an upsized underwritten public offering of 6,470,588 shares of common stock at $17.00 per share, with expected gross proceeds of approximately $110 million. The company intends to use the net proceeds to repay loans, settle litigation, and support working capital and general corporate purposes. The offering is managed by Goldman Sachs & Co. LLC, Morgan Stanley, and Wells Fargo Securities and is subject to customary closing conditions.

diagnostics_research DGX
$171.06
price up icon 0.03%
diagnostics_research LH
$221.08
price up icon 0.52%
diagnostics_research WAT
$347.11
price up icon 4.57%
$151.60
price up icon 5.64%
diagnostics_research MTD
$1,051.45
price up icon 4.05%
diagnostics_research IQV
$151.92
price up icon 4.35%
자본화:     |  볼륨(24시간):